Molecular autopsy in young sudden cardiac death victims with suspected cardiomyopathy

M K Larsen1, P H Nissen, K E Berge

  • 1Department of Forensic Medicine, Faculty of Health Sciences, Aarhus University, Aarhus N, Denmark. ml@forensic.au.dk

Insights

Pathogenic mutations were identified in 9.8% of young sudden cardiac death (SCD) victims suspected of cardiomyopathy. Genetic screening revealed mutations in genes linked to hypertrophic, dilated, and arrhythmogenic cardiomyopathies.

Area of Science:

  • Cardiovascular Genetics
  • Forensic Medicine
  • Molecular Pathology

Background:

  • Sudden cardiac death (SCD) in young individuals (0-40 years) often involves underlying cardiomyopathies.
  • Genetic factors play a significant role in the etiology of these heart muscle diseases.
  • Comprehensive genetic screening is crucial for understanding SCD mechanisms.

Purpose of the Study:

  • To identify and characterize pathogenic mutations in a cohort of young SCD victims with suspected cardiomyopathy.
  • To determine the frequency of genetic variants in genes associated with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and arrhythmogenic right ventricle cardiomyopathy (ARVC).
  • To contribute to the understanding of the genetic basis of SCD in the young population.

Main Methods:

  • Genetic screening of 41 cases from forensic medicine databases.
  • DNA sequencing to detect mutations in key cardiomyopathy-associated genes (MYBPC3, MYH7, LMNA, PKP2, TMEM43).
  • Analysis of sequence variants to identify presumed pathogenic mutations.

Main Results:

  • Rare sequence variants were found in 9 out of 41 cases (22%).
  • Four cases (9.8%) harbored presumed pathogenic mutations.
  • Identified mutations included MYH7 (p.R442H) in suspected HCM/DCM, LMNA (p.R471H) in suspected DCM, and PKP2 (p.R79X) and LMNA (p.R644C) in suspected ARVC.

Conclusions:

  • Genetic mutations are present in a significant proportion of young SCD victims with suspected cardiomyopathy.
  • Molecular autopsy is essential for identifying genetic causes of SCD in post-mortem examinations.
  • These findings highlight the importance of genetic evaluation in SCD cases with cardiac structural anomalies.